Alerts will be sent to your verified email
Verify Email
AKUMS
|
Akums Drugs & Pharma
|
Marksans Pharma
|
Sanofi India
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
DMF Filingsby API
|
20.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
0.7 % | 3.0 % | 0.0 |
|
Financials
|
|||
|
5 yr Average ROE
|
7.64 % | 17.57 % | 52.02 % |
|
5yr average Equity Multiplier
|
3.58 | 1.33 | 4.62 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 0.9 | 0.47 |
|
5yr Avg Net Profit Margin
|
1.67 % | 14.56 % | 24.38 % |
|
Price to Book
|
2.42 | 2.86 | 9.06 |
|
P/E
|
23.93 | 21.35 | 18.86 |
|
5yr Avg Cash Conversion Cycle
|
41.09 Days | 71.65 Days | 4.83 Days |
|
Inventory Days
|
60.56 Days | 89.77 Days | 66.8 Days |
|
Days Receivable
|
71.09 Days | 65.99 Days | 31.98 Days |
|
Days Payable
|
82.93 Days | 88.81 Days | 63.37 Days |
|
5yr Average Interest Coverage Ratio
|
6.25 | 38.03 | 906.11 |
|
5yr Avg ROCE
|
6.7 % | 21.95 % | 27.19 % |
|
5yr Avg Operating Profit Margin
|
6.07 % | 20.32 % | 24.71 % |
|
5 yr average Debt to Equity
|
0.43 | 0.02 | 0.0 |
|
5yr CAGR Net Profit
|
22.48 % | 10.03 % | 31.63 % |
|
5yr Average Return on Assets
|
1.78 % | 13.19 % | 11.5 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.26 % | 43.87 % | 60.4 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -5.13 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
6.05 % | 3.45 % | 0.06 % |
|
Akums Drugs & Pharma
|
Marksans Pharma
|
Sanofi India
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|